Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (19)

1

Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease : A Review of Comparative Effectiveness Studies

enthalten in: Journal of clinical medicine | 2024

von Sharip, M. | Nishad, N. | Pillay, L. | +3

2

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings

enthalten in: Rheumatology (Oxford, England) | 2024

von Sayers, S. | Lam, D. | Shah, Q. | +12

3

Biologic therapy for inflammatory bowel disease : Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource

enthalten in: Journal of Crohn's & colitis | 2023

von Kapizioni, C. | Desoki, R. | Lam, D. | +15

CommentIn: J Crohns Colitis. 2024 Jan 17;:. - PMID 38233095

4

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients

enthalten in: Digestive diseases and sciences | 2023

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

5

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

6

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

7

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

8

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13] : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Smith, P. | Critchley, L. | Storey, D. | +17

9

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

in: BMC Health Services Research | 2022

von Hyun Kyeong Yoo | Han Geul Byun | Flavio Caprioli | +5

10

Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease

enthalten in: Digestive diseases and sciences | 2021

von Rhodes, J. | Subramanian, S. | Flanagan, P. | +10

CommentIn: Dig Dis Sci. 2021 Aug;66(8):2478-2480. - PMID 32880798